Abstract: A deforming method for a deformable mirror having plural electrodes and a reflective membrane which are distorted by static voltages. The Zernike voltage template used to deform a deformable mirror is adapted for aberration correction by calibrating each component template according to the specificity of the mirror. The voltages applied to the electrodes to form a surface profile of the reflective membrane are measured based on the reflection light from the membrane. A certain number of voltage-by-electrode patterns each of which corresponds to a different reference profile of the reflective membrane and specifies each set of a voltage and an electrode to which the voltage is to be applied are stored preliminarily. The reflective membrane is deformed to a desired profile by superposing preliminarily stored voltage-by-electrode patterns. The deformation of the mirror is corrected by calibrating each template according to the operational environment.

Abstract: The present invention uses site diversity reception and RAKE combining reception for the method for a CDMA communication mobile terminal to carry out a cell search to search for a base station with which to communicate. Even if the reception power levels of synchronization acquisition signals sent from a plurality of base stations are lower than a predetermined threshold, in the case where the power level of a signal combining those signals is equal to or greater than the predetermined threshold, the mobile terminal continues processing of requesting position registration to any one of the plurality of base stations and thereby improves communicability.

Abstract: L-Ascorbic acid-2-O-maleic acid-&agr;-tocopherol diester.1-propanol adduct or its pharmacologically acceptable salt; cosmetic components, antioxidants, radical scavengers, anti-inflammatory agents and elastase inhibitors containing the same as the active ingredient; and a process for producing the above-described adduct characterized by comprising extracting a solution containing L-ascorbic acid-2-O-maleic acid-&agr;-tocopherol diester with a solvent, distilling off the solvent, and adding to the residue 1-propanol mixed with an organic solvent followed by crystallization.

Abstract: The constitution of a further miniaturization of a mold pin is provided which improves concentrative mounting of the mold pin and simplifies a fixing cable to the press-fitting pin. A mold pin for cable terminal forms soldered portions for fixing conductive lines protruding from the connecting end of cable at the base end of each of the press-fitting pins where the soldered portions form notch portions and at proper positions of its edge portion and solder in such a manner that the conductive lines of the cable connecting ends are inserted into the notch portions and the notch portions fills with the conductive line to an appropriate thickness, and buries the soldered portion inside the resin mold body.

Abstract: L-Ascorbic acid-2-O-maleic acid-&agr;-tocopherol diester.1-propanol adduct or its pharmacologically acceptable salt; cosmetic components, antioxidants, radical scavengers, anti-inflammatory agents and elastase inhibitors containing the same as the active ingredient; and a process for producing the above-described adduct characterized by comprising extracting a solution containing L-ascorbic acid-2-O-maleic acid-&agr;-tocopherol diester with a solvent, distilling off the solvent, and adding to the residue 1-propanol mixed with an organic solvent followed by crystallization.

Abstract: According to the present invention, there are provided diester compounds of maleic acid (or fumaric acid) or their pharmacologically acceptable salts represented by the formula: 1

Abstract: The present invention uses site diversity reception and RAKE combining reception for the method for a CDMA communication mobile terminal to carry out a cell search to search for a base station with which to communicate. Even if the reception power levels of synchronization acquisition signals sent from a plurality of base stations are lower than a predetermined threshold, in the case where the power level of a signal combining those signals is equal to or greater than the predetermined threshold, the mobile terminal continues processing of requesting position registration to any one of the plurality of base stations and thereby improves communicability.

Abstract: A method for preparing an ultrafine powder, which comprises forming a precipitate by reacting a hydroxide type precipitate-forming agent to an aqueous solution containing at least one type of metal ions capable of forming a hydroxide type precipitate which forms a stable floc in the presence of sulfate ions, adding sulfate ions before or after forming the precipitate, to let the formed precipitate form a stable floc, and then dispersing the precipitate in an organic solvent without drying it, followed by drying to obtain independently separated amorphous or crystalline primary particles having an average particle size of at most 0.2 .mu.m.

Abstract: This invention provides a phosphoric diester of formula (I) which is available on di-esterification of phosphoric acid with L-ascorbic acid involving its 5-hydroxyl group and tocopherol involving its hydroxyl group or a pharmacologically acceptable salt thereof. ##STR1## The compound of the invention can be used with advantage as an antioxidant (radical-scavenging) agent and a prophylactic and therapeutic agent for ischemic organ disorders (e.g. myocardial infarction, heart failure, arrhythmia, cerebral infarction, stroke (cerebral apoplexy), renal failure, etc.).

Abstract: The present invention provides man-made saliva fluids which contain lysozyme chloride in such concentrations as may be able to suppress effectively the development of oral edema and which possess improved feeling of use and show lessened change in appearance and pH value as well as minimized reduction in enzymatic activity of lysozyme chloride after a prolonged period of storage.

Abstract: A pharmaceutical composition for renal disorder and a dialysis solution for extracorporeal hemodialysis which comprise a phosphoric acid diester of the following formula: ##STR1## (wherein R.sub.1 and R.sub.2 are the same or different and each represents a hydrogen atom or a methyl group) or a pharmacologically acceptable salt thereof.Since the composition of this invention inhibits the formation of free radicals in the body, it can be advantageously used for the prophylaxis and treatment of various renal disorders such as glomerulonephritis, acute renal failure, uremia, adriamycin nephrosis, puromycin nephrosis, gentamicin- and cisplatin-induced disorders of the kidney, renal impairment due to paraquat and other agricultural chemicals, and immune complex nephritis. Moreover, the composition of this invention is also of use as a dialysis solution for extracorporeal hemodialysis with the propylactic/therapeutic effect on dialysis amyloidosis.

Abstract: A two-pack hair treatment composition comprising a first lotion containing a reducing substance (a) and a cationic polymer (b) and a second lotion containing an anionic surfactant or amphoteric surfactant (c) and a lubricant (d), wherein the first lotion is applied to the hair first and then the second lotion is applied thereto.The process of the present invention for treating the hair with the above-described two-pack hair treatment composition comprises treating the hair with the first lotion, leaving the hair to stand for a predetermined period of time and, if necessary, subjecting it to intermediate rinsing, applying the second lotion to the hair, leaving the hair stand again for a predetermined period of time, and finally rinsing the hair.

Abstract: A pharmaceutical composition containing urokinase and a physiological absorption enhancer comprising higher fatty acids, a polyalkylene glycol and calcium is disclosed. Whereas urokinase which is decomposed and inactivated in the stomach and is poorly absorbed from the intestinal tract cannot be orally administered, it can be orally administered in the form of the present composition by applying an enteric coating, because urokinase in the composition is highly absorbable from the intestinal tract. It is desirable in the present composition in view of the stability and sustained absorbability that urokinase is contained in said composition in the form of a liposome preparation in which the urokinase is incorporated in voids of the liposome. The components are incorporated in the present composition at a ratio of 0.01-2 mg. of the higher fatty acid, 0.01-5 mg. of the polyalkylene glycol and 0.0001-0.1 mg. of the calcium per 100 units of urokinase.